Tianbao Lu

1.9k total citations
36 papers, 1.1k citations indexed

About

Tianbao Lu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Tianbao Lu has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Tianbao Lu's work include Cancer-related Molecular Pathways (8 papers), Chemical Synthesis and Analysis (8 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Tianbao Lu is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Chemical Synthesis and Analysis (8 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Tianbao Lu collaborates with scholars based in United States, China and Belgium. Tianbao Lu's co-authors include Daniel J. Parks, Maxwell D. Cummings, Karen L. Milkiewicz, Raul R. Calvo, Jennifer Lattanze, Juan Marugán, Louis V. LaFrance, Mark R. Player, Bruce E. Tomczuk and Bruce Grasberger and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Tianbao Lu

36 papers receiving 1.0k citations

Peers

Countries citing papers authored by Tianbao Lu

Since Specialization

Citations

This map shows the geographic impact of Tianbao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianbao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianbao Lu more than expected).

Fields of papers citing papers by Tianbao Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianbao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianbao Lu. The network helps show where Tianbao Lu may publish in the future.

Co-authorship network of co-authors of Tianbao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianbao Lu. A scholar is included among the top collaborators of Tianbao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianbao Lu. Tianbao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL 2022 ·Cancer Discovery ·Min Xia, Liron David, Matt Teater, Johana Gutierrez, (unknown), Cem Meydan, Andrew Lytle, Graham W. Slack, David W. Scott, Ryan D. Morin, Özlem Önder, Kojo S.J. Elenitoba‐Johnson, Nahuel Zamponi, Leandro Cerchietti, Tianbao Lu, Ulrike Philippar, Lorena Fontán, Hao Wu, Ari Melnick	12
2	Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists 2019 ·Bioorganic & Medicinal Chemistry Letters ·Fengbin Song, Guozhang Xu, Michael D. Gaul, Baoping Zhao, Tianbao Lu, Rui Zhang, Renée L. DesJarlais, (unknown), Norman Huebert, Brian C. Shook, (unknown), (unknown), Annette Eckardt, Keith T. Demarest	18
3	Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes 2017 ·Clinical Rheumatology ·Tianbao Lu, Ming Zong, Shasha Fan, Ying Lü, (unknown), Lieying Fan	17
4	Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis 2017 ·Scientific Reports ·Ying Lü, Shanshan Yu, Ming Zong, Shasha Fan, Tianbao Lu, (unknown), (unknown), Lieying Fan	47
5	Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla, Hui Huang, Carl R. Illig, Daniel J. Parks, (unknown), (unknown), Kenneth J. Wilson, Sharmila Patel, Wing S. Cheung, Tianbao Lu, Thomas Kirchner, (unknown), John G. Geisler, Raymond J. Patch, Alan C. Gibbs, (unknown), Margery A. Connelly, Mark R. Player	11
6	Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis 2015 ·Arthritis Research & Therapy ·Ming Zong, Tianbao Lu, Shasha Fan, Hui Zhang, (unknown), (unknown), Zhiyan Fu, Lieying Fan	37
7	JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models. 2008 ·Cancer Research ·Timothy Perera, (unknown), (unknown), (unknown), Peter King, Laurence Mévellec, Maxwell D. Cummings, Tianbao Lu, Dana L. Johnson, Martin Pagé	20
8	Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif 2008 ·Bioorganic & Medicinal Chemistry Letters ·K. D. Kreutter, Tianbao Lu, Lily Lee, Edward C. Giardino, Sharmila Patel, Hui Huang, Guozhang Xu, Mark Fitzgerald, Barbara J. Haertlein, V. Mohan, Carl Crysler, Stephen Eisennagel, Malini Dasgupta, Martin McMillan, John Spurlino, Norman Huebert, Bruce E. Maryanoff, Bruce E. Tomczuk, Bruce P. Damiano, Mark R. Player	24
9	A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese 2008 ·Tissue Antigens ·(unknown), (unknown), (unknown), Ming Zong, Lili Yang, (unknown), (unknown), Tianbao Lu, (unknown)	29
10	2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Lily Lee, K. D. Kreutter, Wenxi Pan, Carl Crysler, John Spurlino, Mark R. Player, Bruce E. Tomczuk, Tianbao Lu	35
11	Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo, Karen L. Milkiewicz, Juan Marugán, Pierre Raboisson, Carsten J. Schubert, Holly K. Koblish, Shuyuan Zhao, Carol F. Franks, Jennifer Lattanze, Theodore E. Carver, Maxwell D. Cummings, Diane Maguire, Bruce Grasberger, Anna C. Maroney, Tianbao Lu	57
12	Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa 2006 ·Chemical Biology & Drug Design ·Bruce E. Maryanoff, David F. McComsey, Michael J. Costanzo, Stephen C. Yabut, Tianbao Lu, Mark R. Player, Edward C. Giardino, Bruce P. Damiano	19
13	Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity 2006 ·Bioorganic & Medicinal Chemistry Letters ·Kristi Leonard, Juan Marugán, Pierre Raboisson, Raul R. Calvo, (unknown), Holly K. Koblish, Jennifer Lattanze, Shuyuan Zhao, Maxwell D. Cummings, Mark R. Player, Anna C. Maroney, Tianbao Lu	49
14	Substituted 1,4‐Benzodiazepine‐2,5‐diones as α‐Helix Mimetic Antagonists of the HDM2‐p53 Protein–Protein Interaction 2006 ·Chemical Biology & Drug Design ·Maxwell D. Cummings, Carsten J. Schubert, Daniel J. Parks, Raul R. Calvo, Louis V. LaFrance, Jennifer Lattanze, Karen L. Milkiewicz, Tianbao Lu	37
15	Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Juan Marugán, Kristi Leonard, Pierre Raboisson, (unknown), Raul R. Calvo, Holly K. Koblish, Jennifer Lattanze, Shuyuan Zhao, Maxwell D. Cummings, Mark R. Player, Carsten J. Schubert, Anna C. Maroney, Tianbao Lu	23
16	Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Pierre Raboisson, Juan Marugán, Carsten J. Schubert, Holly K. Koblish, Tianbao Lu, Shuyuan Zhao, Mark R. Player, Anna C. Maroney, (unknown), Norman Huebert, Jennifer Lattanze, Daniel J. Parks, Maxwell D. Cummings	41
17	1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR 2004 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo, Karen L. Milkiewicz, Varsha Gupta, Jennifer Lattanze, (unknown), Theodore E. Carver, Eugene C. Petrella, Maxwell D. Cummings, Diane Maguire, Bruce Grasberger, Tianbao Lu	130
18	Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bruce E. Tomczuk, Tianbao Lu, Richard Söll, (unknown), Aihua Wang, (unknown), Carl Crysler, Malini Dasgupta, Stephen Eisennagel, John Spurlino, Roger Bone	24
19	Structure–activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor 2000 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu, Richard Söll, Carl R. Illig, Roger Bone, (unknown), John Spurlino, F. Raymond Salemme, (unknown)	11
20	In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu, Bruce E. Tomczuk, Carl R. Illig, Roger Bone, (unknown), John Spurlino, F. Raymond Salemme, Richard Söll	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact